The downside-clusters view highlights where urgency will outrun proof quality if concentrated risk is left alone too long.
| Owner | Audience | Urgency | Board confidence | Headline |
|---|---|---|---|---|
| AI operating partner | Board strategy committee | 53 | 92 | AI should be protected because it is already compounding trust, not merely consuming budget. |
| Security operating lead | Risk committee | 82 | 74 | Identity has concentrated downside because multiple spend paths still resolve into one board question. |
| Revenue systems partner | Operating committee | 74 | 84 | Revenue deserves increased allocation where margin recovery is already visible and measurable. |
| FinTech diligence lead | Investor diligence committee | 71 | 69 | FinTech should hold for now because the downside is still clustered more tightly than the upside is diversified. |
| Quality systems sponsor | Regulated growth committee | 48 | 91 | Biotech allocation should be protected because the downside is low and the flagship quality story is already coherent. |
| Procurement intelligence lead | Go-to-market committee | 79 | 77 | Procurement is over-allocated in overlapping proof paths and is ready for savings recovery through consolidation. |